Agenda

Capital, Scale & Europe Without borders
& State of the union

09.00
Registration & Welcome Coffee
09.30
Finance & Scale Breakfast: Curated Networking
11.00
Life Sciences & Healthtech Scale-up Showcase
  • Rudi Tielemans, Founder & CEO, Eforto Health
  • Katrien Reynders-Frederix, CEO & Co-Founder, NanoTherix
  • Jan Van der Schueren, CEO/CSO, Co-Founder, Alturos Therapeutics
  • Kevin Hollevoet,
    CEO & Co-founder
    Hemastatx
  • Ken Coppieters, Sr. Director, Rare Disease, Research Portfolio, Novo Nordic
Workshop: Design Your Exit Before You Start
Working backwards from realistic exit scenarios (trade sale, licensing deal, IPO, acqui-hire) to stress-test whether today’s decisions are aligned with tomorrow’s outcome. Especially relevant in the current BeNeLux M&A climate.
11.45
Life Sciences & Healthtech Scale-up Showcase
Workshop for Startups 2
12.30
Networking Lunch
13.30
Arrival & Registration for the State of the Union
14.00
Opening & Introduction of the State of the Union

Ann Van Gysel, CEO, Biovia

14.30
International Keynote: Building Global Life Sciences Champions
15.00
Panel: Join Forces or Lose Ground: The Only Way Europe Wins Is Together

This panel explores why strategic collaboration between European clusters is becoming a competitive necessity, and how joining forces across borders creates the critical mass needed to attract investment, talent and international partnerships. The panel will examine what a true “Champions League” of European life sciences and healthtech innovation could look like in practice, and what it takes to get there.

Speakers:

  • Anette Steenberg, CEO, Medicon Valley Alliance
  • Ann Van Gysel, CEO, Biovia
  • James Rose, Director of Strategic and Industry Partnerships, Health Innovation Oxford & Thames Valley
  • Alexander Becker, Head of Innovation and Entrepreneurship, Basel Area Business & Innovation

Moderated by Stamie Kritas, Managing Director, Council of European BioRegions (CEBR)

16.00
Coffee break
16.30
Fireside Chat: Financial Insights
  • Jeroen Van Den Bossche, Director Equity Sales Life Sciences, KBC Securities
  • TBA, PMV

Moderated by Clément Salque, Senior Associate, Bioqube Ventures

17.15
The Money Is Out There. So Why Can’t You Get It?
  • Katleen Vandersmissen, Managing Partner, Heran Partners
  • Jerome van Biervliet, Managing Director, VIB, representing of The European Life Sciences Coalition (ELSC)
  • TBA

Moderated by Laurent Van Lerberghe, Founder, KELES

18.00
Walking Dinner

Flanders on Display

08.45
Registration & Welcome Coffee
09.00
Partnering Opens
Exhibition Opens
10.00
Welcome words
  • Els Van Doesburg, Mayor, City of Antwerp
  • Miranda Coppens, General Manager POM Antwerp
  • Ann Van Gysel, CEO, Biovia
10.15
International keynote: Scientific Sovereignty is not enough – time for more industrial leadership
10.45
Keynote: How to scale a biotech company

Tim Knotnerus, CEO, Agomab Therapeutics

11.05
Panel: Navigating Life Sciences Journey with eyes wide open
  • Stephane van Rooijen, CEO, Life Sciences
  • Edwin Moses, Chairman of the Board at LabGenius, NanoSyrinx, and Avantium

Moderated by Henry Stoneley, Founder, Rabble Rouser Go to Market

11.45
Panel: The World Won’t Wait for Europe to Figure Out Scaling
  • Viggo Van Tendeloo, Director Early Innovation Partnering Benelux, Johnson&Johnson
  • Ilse Vanhulle, Venture Acceleration Manager Health, imec istart
  • Christina Takke, Managing Partner, V-Bio Ventures
  • Emile Redant, CEO, Zymofix
  • Lukas Stabel, Business Developer, Comate
12.30
Networking Lunch
13.30
Networking Lunch
TTO Session: spin off pitches – from academy to the market
14.00
No borders, just breakthroughts: Tech for One health pitches
TTO Session: spin off pitches – from academy to the market
15:00
Champions of innovation: Personalized medicine
Champions of innovation: Value-based healthcare
  • Heidi Bertels and Sofie Rennen, Sampl.id
Champions of innovation: Clinical trials

 

Champions of innovation: Agtech & industrial biotech
16:00
Coffee Break
16.30
Closing fireside chat: “Surviving in a tough economy…a new playbook for innovation”
  • Wim Van Hecke, CEO, Icometrix
  • Steven Biesmans, Principal, UCB Ventures

Moderated by Ann Van Gysel, CEO, Biovia

17.30
Reception

Nullam quis risus eget urna mollis ornare vel eu leo. Aenean lacinia bibendum nulla sed